Which company develops and produces Mitotane?

Mitotane (Mitotane), is a drug in the field of rare diseases, developed and produced by HRA Pharma Rare Diseases. HRA Pharma Rare Diseases is a biopharmaceutical company focused on the treatment of rare diseases. It is committed to developing innovative treatments to meet the special needs of those patients with rare diseases.

Mitotan is commonly used to treat pheochromocytoma (pheochromocytoma) and pheochromocytoma (paraganglioma), which are rare diseases that usually originate in the adrenal glands or other ganglia and lead to excessive secretion of dopamine, norepinephrine, and epinephrine, causing high blood pressure and other serious symptoms. Mitotane works by inhibiting adrenocortical function, thereby reducing the production of these hormones, helping to reduce symptoms and improve patients' quality of life.

Drug research and development in this area of rare diseases is critical to providing the treatment options patients need, as traditional drug development often focuses on common diseases. HRA Pharma Rare Diseases’s work represents the medical field’s commitment to providing patients with rare diseases with a better quality of life and hope.

Patients and physicians should conduct treatment under the guidance of a medical professional when using mitotane or any rare disease treatment drug and strictly follow the recommended dosage and monitoring regimen to ensure safety and effectiveness. Research and innovation in this area will continue to have a positive impact on rare disease patients and provide them with more treatment options.

Mitotane has not yet been launched in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs abroad. The Turkish version of the original drug is about more than 7,000 yuan, followed by the European version of the original drug, which is about 9,000 yuan. There are also cost-effective generic drugs, mainly Laos and ASEAN generic drugs. The price is about more than 3,000 yuan. The ingredients of the original drugs and generic drugs are the same.